(Q48230536)

English

The alkylating agent EEDQ facilitates protease-mediated degradation of the human brain alpha2A-adrenoceptor as revealed by a sequence-specific antibody

scientific article published in March 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

The alkylating agent EEDQ facilitates protease-mediated degradation of the human brain alpha2A-adrenoceptor as revealed by a sequence-specific antibody (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

author name string

Ozaita A

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

Escribá PV

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

García-Sevilla JA

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

language of work or name

0 references

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Neuroscience Letters

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

263

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

2-3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

105-108

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 2-adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Assembly of asparagine-linked oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein oxidation and aging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900118-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0304-3940(99)00118-4

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

release_hi3xykfxengurdvrhbbfp4ondm

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/10213146

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48230536&oldid=2192246942"